Megapharm to market Kineret and Kepivance in Israel
This article was originally published in Scrip
Executive Summary
Megapharm is to exclusively distribute and market Biovitrum's Kineret (anakinra) and Kepivance (palifermin) in Israel for five years. Financial details were not disclosed.